Innovative programs for integrated delivery systems.
These programs are most effective under a MCO setting, but will succeed only if there are individuals within the organization to champion these programs. Many pharmacists have taken the lead and are working closely with manufacturers to identify the best use of these programs. These individuals ensure that the programs are implemented and that the appropriate pathways are followed. The pharmacist can assist in identifying those who are not using products appropriately. Using the manufacturer's resources (sales force) to supply the provider with educational material can help the provider follow the pathways and focus on appropriate use. The pharmacist can monitor the data and offer suggestions on program modifications. Therefore, the pharmacist plays a key role in meeting the challenges presented by outcomes performance programs and in creating an opportunity for the patient care organization to achieve its financial goals. With the MCO and manufacturer as partners, these programs will be successful and can increase the quality of care to MCO members who receive care in an institutional or community managed care setting.
J
J
Drapkin
D002204:Capitation Fee; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D008329:Managed Care Programs / Q000191:economics / Q000458:organization & administration*; D010593:Pharmaceutical Services / Q000191:economics*; D016896:Treatment Outcome; D014481:United States